Enovis Cash Flow from Operating Activities 2010-2024 | ENOV
Enovis cash flow from operating activities from 2010 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
| Enovis Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2023 | $135 |
| 2022 | $-56 |
| 2021 | $356 |
| 2020 | $302 |
| 2019 | $131 |
| 2018 | $226 |
| 2017 | $219 |
| 2016 | $247 |
| 2015 | $304 |
| 2014 | $386 |
| 2013 | $362 |
| 2012 | $174 |
| 2011 | $57 |
| 2010 | $62 |
| 2009 | $39 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.875B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.366B | 20.52 |
| Inspire Medical Systems (INSP) | United States | $4.612B | 0.00 |
| Axonics (AXNX) | United States | $3.446B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.129B | 0.00 |
| 10x Genomics (TXG) | United States | $2.980B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.978B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.950B | 0.00 |
| Azenta (AZTA) | United States | $2.743B | 154.15 |
| Privia Health (PRVA) | United States | $2.016B | 112.67 |
| Schrodinger (SDGR) | United States | $1.654B | 0.00 |
| Omnicell (OMCL) | United States | $1.398B | 48.32 |
| Phreesia (PHR) | United States | $1.393B | 0.00 |
| Standard BioTools (LAB) | United States | $0.746B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.662B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.649B | 0.00 |
| Talkspace (TALK) | United States | $0.467B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.442B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.410B | 0.00 |
| Pulmonx (LUNG) | United States | $0.349B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.296B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.217B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.191B | 0.00 |
| Outset Medical (OM) | United States | $0.187B | 0.00 |
| American Well (AMWL) | United States | $0.145B | 0.00 |
| TruBridge (TBRG) | United States | $0.134B | 7.19 |
| 111 (YI) | China | $0.111B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.107B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.070B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.064B | 0.00 |
| Augmedix (AUGX) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.054B | 0.00 |
| CareCloud (CCLD) | United States | $0.045B | 0.00 |
| Movano (MOVE) | United States | $0.042B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Cue Health (HLTH) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Syra Health (SYRA) | United States | $0.010B | 0.00 |
| Biotricity (BTCY) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |